Cost-utility of treatment of the patients with Thalassemia Major in Iran
Journal Title: Khoon - Year 2019, Vol 15, Issue 4
Abstract
Cost-utility of treatment of the patients with Thalassemia Major in Iran Emamgholipour S.1, Ahmadi B.1, Rajabi A.2, Azarkeivan A.3,4, Ebrahimi M.3,4, Esmaeilzadeh F.5 1School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 2Golestan University of Medical Sciences, Gorgan, Iran 3Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran 4Adult Thalassemia Clinic, Tehran, Iran 5Department of Public Health, School of Public Health, Maragheh University of Medical Sciences, Maragheh, Iran Abstract Background and Objectives Thalassemia major is an autosomal recessive disease with serious morbidity, mortality and pathology. Due to today’s therapeutic advances, the life expectancy of thalassemia patients has significantly increased. As a result, thalassemia patients need lifelong care, but caring for patients with thalassemia causes a lot of costs. Therefore, being aware of the costs and effectiveness of the treatments is essential for controlling the costs and providing effective treatments. Materials and Methods In this cross-sectional descriptive study, a bottom-up method was used to estimate the treatment costs for thalassemia patients and all the costs were estimated over a one-year period (2015). The number of QALYs created by treatment was also extracted using the EQ5D questionnaire, and eventually, the Markov model was used to calculate the costs and effectiveness for patients’ longevity. Results Treatment for any patients with thalassemia major costs $ 8,321.8 per year. Applying a 3% discount rate, we estimated that each patient lifelong treatment costs $ 147,098.4, which would results in 11.8 QALYs. Hence, the cost per QALY would be $ 12,466,0. Conclusions Treating the patients with thalassemia major, despite its cost effectiveness, might cost a lot so that the treatment of the patients in the fourth decade of their lives may even reach the cost-effectiveness threshold. Therefore, increasing the costs in the field of patient screening and prevention of the birth of patients with thalassemia major seems to be useful. Key words: Cost-Benefit Analysis, beta-Thalassemia, Iran Received: 30 Apr 2018 Accepted:14 Aug 2018 Correspondence: Esmaeilzadeh F., PhD in Health Economics. Assistant Professor of Department of Public Health, School of Public Health, Maragheh University of Medical Sciences. Postal Code: 5515878151, Maragheh, Iran. Tel: (+9841) 37256926; Fax: (+9841) 37256901 E-mail: firooz.esmaeilzadeh@gmail.com
Authors and Affiliations
S. Emamgholipour, B. Ahmadi, A. Rajabi, A Azarkeivan, M. Ebrahimi, F. Esmaeilzadeh
Keywords
Related Articles
- EP ID EP522334
- DOI -
- Views 93
- Downloads 0
تعيين ژنوتيپ ويروس هپاتيت B در استان گلستان
تعيين ژنوتيپ ويروس هپاتيت B در استان گلستان عبدالوهاب مرادي1، وحيده كاظمي‌نژاد2، علي‌اصغر مولانا3، مسعود بازوري4 چكيده سابقه و هدف حدود 5% جمعيت دنيا به ويروس هپاتيت B آلوده هستند. عفونت با اين ويروس، موجب آس...
رابطه گروه‌هاي خوني با نوع باكتري عامل عفونت‌هاي ادراري در بيماران مراجعه كننده به آزمايشگاه‌هاي دانشگاه شهيد صدوقي يزد
رابطه گروه‌هاي خوني با نوع باكتري عامل عفونت‌هاي ادراري در بيماران مراجعه كننده به آزمايشگاه‌هاي دانشگاه شهيد صدوقي يزد دكتر نسرين قاسمي1، دكتر جمشيد آيت‌اللهي2، احمد مصدق3، سيد مهدي مهدوي4 چكيده سابقه و هدف آنت...
The Efficacy impact of donor temporary deferal on the safety of blood donations in Iran during the years 2012-2014
The Efficacy impact of donor temporary deferal on the safety of blood donations in Iran during the years 2012-2014 Hatami H.1, Maghsudlu M.2, Balali M.R.2, Seyfi Targhi M.M.2 1School of Public Helath and Safety, Sha...
Analysis of the confidential report of positive screening results to the Iranian Ministry of Health and Medical Education Within the framework of the principle of confidentiality in Blood Transfusion
Analysis of the confidential report of positive screening results to the Iranian Ministry of Health and Medical Education Within the framework of the principle of confidentiality in Blood Transfusion Asghari A.1, Pour...
Gamma irradiation, an appropriate method for sterilization of the fibrin membrane while maintaining its biocompatibility characteristics
Gamma irradiation, an appropriate method for sterilization of the fibrin membrane while maintaining its biocompatibility characteristics Akbari Saied T.1, Ahmadi M.2, Fatemi A.3, Farsinejad A.R.4 1Sirjan University...